US FDA urges caution on Amgen, J&J anemia drugs – Reuters

Posted by on Jun 25th, 2011 and filed under Medical News. You can follow any responses to this entry through the RSS 2.0. You can leave a response or trackback to this entry

US FDA urges caution on Amgen, J&J anemia drugs – Reuters


ThirdAge

US FDA urges caution on Amgen, J&J anemia drugs
Reuters
NEW YORK, June 24 (Reuters) – US health regulators urged on Friday more conservative dosing for widely used anemia drugs from Amgen Inc (AMGN.O) and Johnson & Johnson (JNJ.N) because of the risk of heart problems.
FDA: New Warning for Procrit, Epogen, AranespWebMD
FDA Issues New Warnings For Anemia Drugs In Kidney-Disease PatientsWall Street Journal
FDA Urges Tailored Dosing for Anemia DrugsMedPage Today
Boston Globe –USA Today
all 175 news articles »

Leave a Reply

    Copyright 2011-2013, www.EHealthJournal.net, Web Site Development & SEO by SecondEffort, Inc.